These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 25068731

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis of New Harmine Isoxazoles and Evaluation of their Potential Anti-Alzheimer, Anti-inflammatory, and Anticancer Activities.
    Filali I, Romdhane A, Znati M, Jannet HB, Bouajila J.
    Med Chem; 2016; 12(2):184-90. PubMed ID: 26362768
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine.
    Filali I, Belkacem MA, Ben Nejma A, Souchard JP, Ben Jannet H, Bouajila J.
    J Enzyme Inhib Med Chem; 2016; 31(sup1):23-33. PubMed ID: 27028352
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase.
    Sukhorukov AY, Nirvanappa AC, Swamy J, Ioffe SL, Nanjunda Swamy S, Basappa, Rangappa KS.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3618-21. PubMed ID: 24909082
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents.
    Venugopala KN, Govender R, Khedr MA, Venugopala R, Aldhubiab BE, Harsha S, Odhav B.
    Drug Des Devel Ther; 2015 Aug 01; 9():911-21. PubMed ID: 25733811
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease.
    Liu W, Liu X, Liu W, Gao Y, Wu L, Huang Y, Chen H, Li D, Zhou L, Wang N, Xu Z, Jiang X, Zhao Q.
    Eur J Med Chem; 2022 Feb 05; 229():114095. PubMed ID: 34995924
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of New Arylidene 2,5-Diketopiperazines and Evaluation of their Anti-Acetylcholinesterase, Anti-xanthine Oxidase, Anti-diabetic and Cytotoxic Activities.
    Belkacem MA, Jannet HB, Ferhout H, Mzali L, Bouajila J.
    Med Chem; 2017 Feb 05; 13(8):744-752. PubMed ID: 28480832
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.
    Li Z, Wang ZC, Li X, Abbas M, Wu SY, Ren SZ, Liu QX, Liu Y, Chen PW, Duan YT, Lv PC, Zhu HL.
    Eur J Med Chem; 2019 May 01; 169():168-184. PubMed ID: 30877972
    [Abstract] [Full Text] [Related]

  • 12. In Vitro Evaluation and Docking Studies of 5-oxo-5H-furo[3,2-g]chromene-6-carbaldehyde Derivatives as Potential Anti-Alzheimer's Agents.
    Mphahlele MJ, Gildenhuys S, Agbo EN.
    Int J Mol Sci; 2019 Nov 01; 20(21):. PubMed ID: 31683761
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
    Saeed A, Mahesar PA, Zaib S, Khan MS, Matin A, Shahid M, Iqbal J.
    Eur J Med Chem; 2014 May 06; 78():43-53. PubMed ID: 24675179
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of new anticancer and anti-inflammatory isoxazolines and aziridines from the natural (-)-deltoin.
    Znati M, Debbabi M, Romdhane A, Ben Jannet H, Bouajila J.
    J Pharm Pharmacol; 2018 Dec 06; 70(12):1700-1712. PubMed ID: 30229910
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and cytotoxic activity evaluation of some novel 1-(3-(aryl-4,5-dihydroisoxazol-5-yl)methyl)-4-trihalomethyl-1H-pyrimidin-2-ones in human cancer cells.
    Lobo MM, Viau CM, Dos Santos JM, Bonacorso HG, Martins MA, Amaral SS, Saffi J, Zanatta N.
    Eur J Med Chem; 2015 Aug 28; 101():836-42. PubMed ID: 26275603
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines.
    Burra S, Voora V, Rao CP, Vijay Kumar P, Kancha RK, David Krupadanam GL.
    Bioorg Med Chem Lett; 2017 Sep 15; 27(18):4314-4318. PubMed ID: 28838692
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents.
    Chekir S, Debbabi M, Regazzetti A, Dargère D, Laprévote O, Ben Jannet H, Gharbi R.
    Bioorg Chem; 2018 Oct 15; 80():189-194. PubMed ID: 29940340
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents.
    Cao R, Fan W, Guo L, Ma Q, Zhang G, Li J, Chen X, Ren Z, Qiu L.
    Eur J Med Chem; 2013 Feb 15; 60():135-43. PubMed ID: 23291116
    [Abstract] [Full Text] [Related]

  • 19. Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol.
    Tommonaro G, Pejin B, Iodice C, Tafuto A, De Rosa S.
    J Enzyme Inhib Med Chem; 2016 Aug 15; 31(4):684-6. PubMed ID: 26114310
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, molecular properties, anti-inflammatory and anticancer activities of novel 3-hydroxyflavone derivatives.
    Znati M, Bordes C, Forquet V, Lantéri P, Ben Jannet H, Bouajila J.
    Bioorg Chem; 2019 Aug 15; 89():103009. PubMed ID: 31158579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.